Home > Insider Trading > Filing (0001214659-21-002803)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1581280	Twist Bioscience Corp	TWST	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1222644	P Robert Ragusa	C/O Twist Bioscience Corporation 681 Gateway Blvd. South San Francisco CA 94080		No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-03-03	10,588	$30.41	12,486	No	4	M	Direct
Common Stock	Disposition	2021-03-03	2,299	$132.15	10,187	No	4	S	Direct
Common Stock	Disposition	2021-03-03	6,519	$133.10	3,668	No	4	S	Direct
Common Stock	Disposition	2021-03-03	1,770	$134.04	1,898	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Director Stock Option (right to buy)	Disposition	2021-03-03	10,588	$0.00	10,588	$30.41

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2029-07-22	No	4	M	Direct

Footnotes

Represents the weighted average sales price per share. The shares sold at prices ranging from $131.44 to $132.37 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Represents the weighted average sales price per share. The shares sold at prices ranging from $132.59 to $133.56 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Represents the weighted average sales price per share. The shares sold at prices ranging from $133.61 to $134.47 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
100% of the shares subject to the option vested and became exercisable on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Issuer's first annual meeting of stockholders following the date of grant, subject to the Reporting Person's continuous service through each vesting date.